Where to inject peptides: subcutaneous sites, rotation and technique

Subcutaneous means into the layer of fat between the skin and the muscle. The peptide is absorbed from there into the capillaries over minutes to an hour, which is the steady, predictable uptake nearly every compound page assumes. Any site with a pinchable layer of fat and no major vessels near the surface works. Four are standard.

Peptide doses are small volumes, usually 0.05 to 0.5 mL, drawn into a U-100 insulin syringe. The needle on those syringes is 29, 30 or 31 gauge, where a higher number means thinner, and 31 gauge is close to painless for most people. Length matters more than gauge. Insulin needle lengths run from 4 mm to 12.7 mm (half an inch), and the modern insulin delivery guidance is that 4 to 6 mm needles reach the subcutaneous layer in nearly all adults regardless of body size, with longer needles adding risk of hitting muscle rather than any benefit.

For peptides the common choices are 5/16 inch (8 mm) and 1/2 inch (12.7 mm) syringes, because that is what vendors and pharmacies stock. Either works in the abdomen of most adults at 90 degrees. The 12.7 mm length is the one to pinch for, especially in lean sites like the thigh, so the needle stays in fat. Syringe volume is a separate choice: a 0.3 mL syringe marked to 30 units has finer markings and is easier to read for small doses, a 0.5 mL goes to 50 units, and a 1 mL goes to 100. The units chart covers reading them.

Use a fresh needle for every injection. They dull after a single pass through a rubber stopper and skin, and a dulled needle hurts more, bruises more and tears tissue. Needles for reconstituting, 18 to 22 gauge on a 3 mL syringe, are for adding water and never for injecting.

With a short needle, 4 to 8 mm, go straight in at 90 degrees with no pinch; the needle is too short to reach muscle through the skin and fat of almost any adult site. With a 12.7 mm needle, or at a lean site with little fat, lift a fold of skin between thumb and finger and inject into the raised fold at 45 degrees. The pinch pulls the fat away from the muscle and the angle keeps the needle in the fold. Release the pinch before pushing the plunger if the fold is tight, so the solution is not squeezed back out.

The sequence is the same either way: swab the site and let it dry, insert the needle in one smooth motion, push the plunger steadily over a few seconds, wait a moment, withdraw at the same angle, and press lightly with a clean swab if there is a drop of blood. Aspirating, pulling back the plunger to check for blood, is not needed for subcutaneous injection and most guidance dropped it years ago.

Rotation means never injecting into the same spot twice in a row and ideally not reusing a spot for a week or more. The reason is tissue damage. Repeated injection into one area causes scarring and lipohypertrophy, a rubbery lump of fat that forms under the skin at overused sites. It is well documented in insulin users and happens with any compound injected daily. Peptide injected into one of those lumps absorbs erratically, so rotation keeps both the tissue healthy and the dose predictable.

The simplest system is a grid. Divide the abdomen into quadrants, work through each quadrant in a pattern, and keep each injection at least an inch from the last. Daily compounds like BPC-157 at twice a day or ipamorelin at bedtime use up abdominal sites quickly, which is where the thighs and flanks come in. Weekly compounds like semaglutide and tirzepatide can rotate across abdomen, thigh and upper arm, which is what their labels describe.

If running two compounds, give each its own area or its own time of day. The TB-500 page notes that people separate it from BPC-157 by hours or by site so a reaction can be traced to one of them.

For most peptides the site is irrelevant to the result. A GLP-1 drug injected in the thigh does what it does in the abdomen, and a growth hormone secretagogue acts on the pituitary wherever it enters the blood. The exception people ask about is BPC-157, which the protocols describe as injected subcutaneously as close to the injury as is practical. The idea is that a higher local concentration helps the tissue underneath.

The evidence is mixed in a useful way. Rodent studies found benefit with both local injection and systemic dosing far from the injury, so proximity is not required for an effect. Whether it adds anything on top is untested in people. The compound page's practical position is that injecting near the injury is a reasonable preference, that the abdomen is fine when the injury is somewhere awkward, and that nobody should inject into a tendon, joint capsule or muscle belly without clinical training. Near means into the fat over the area, not into the structure. Oral vs injectable BPC-157 covers the route question.

A few compounds are sometimes given into muscle: IGF-1 LR3, NAD+, and occasionally TB-500 or HGH by people who want faster uptake. Intramuscular means a longer needle, typically 1 inch (25 mm) and 23 to 25 gauge, at 90 degrees into a large muscle: the outer thigh (vastus lateralis), the upper outer buttock (ventrogluteal), or the deltoid for small volumes. Absorption is faster and the effect comes on sooner, with a shorter tail.

The trade-offs are more soreness, more risk of hitting a vessel or nerve in the wrong spot, and more variation between injections. Nearly every compound page lists subcutaneous as the default because it is easier, steadier and barely hurts, and for small peptide volumes there is rarely a reason to go into muscle.

A small bruise means the needle nicked a capillary. It is harmless and more common in the thigh, with a dull needle, or when the site was rubbed afterward. A pea sized firm lump that appears within a day and softens over a few days is a local reaction to the solution, more common with compounds that sting like GHK-Cu and with higher concentrations.

Lipohypertrophy is the lump that does not go away: rubbery, raised, painless, and the result of weeks of injecting into the same area. The fix is leaving that area alone until it softens, which can take months, and rotating properly from then on. A site that becomes hot, red, increasingly painful or drains anything is not any of these; that is infection and needs a clinician. Fat loss at the site, a dent rather than a lump, is reported with HGH and is another reason its page says rotate.

Used needles and syringes go into a rigid, puncture-resistant container with a lid, sold as a sharps container at any pharmacy for a few dollars. A heavy plastic laundry detergent bottle with a screw cap is the accepted household substitute in most places. Never recap a used needle by hand, never drop loose syringes in household trash or recycling, and never flush them. Fill the container to the line, not the top.

What happens to the full container depends on where you live. Many US states allow sealed household sharps containers in regular trash; others require drop-off at a pharmacy, hospital or hazardous waste site, and some pharmacies run mail-back programs. The UK and Australia generally use pharmacy or council collection. A search for sharps disposal plus your state or council gives the rule.